Tudor Investment Corp’s Immunomedics Inc IMMU Stock Holding History

Tudor Investment Corp’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-530,454	Closed	-$45.1M	–	1760
2020 Q3	$45.1M	Buy	+530,454	New	+$26.8M	1.96%	4
2020 Q1	–	Sell	-13,914	Closed	-$294K	–	1455
2019 Q4	$294K	Sell	13,914 -24,718	-64%	-$436K	0.01%	880
2019 Q3	$512K	Buy	+38,632	New	+$568K	0.02%	705
2015 Q3	–	Sell	-17,600	Closed	-$71K	–	1825
2015 Q2	$71K	Buy	+17,600	New	+$72K	﹤0.01%	1431
2014 Q1	–	Sell	-18,678	Closed	-$86K	–	1477
2013 Q4	$86K	Buy	+18,678	New	+$83.2K	﹤0.01%	1212

Tudor Investment Corp's IMMU Position: Q4 2020 in Review

Tudor Investment Corp sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 530,454 shares — an estimated $45.1M sold.

Tudor Investment Corp first reported a position in IMMU in Q4 2013 and held it in 5 quarters. The position peaked at $45.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Tudor Investment Corp reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Tudor Investment Corp sold 530,454 Immunomedics Inc shares in Q4 2020, an estimated $45.1M.
Tudor Investment Corp first reported a position in Immunomedics Inc in Q4 2013 and held it in 5 quarters.
Tudor Investment Corp's Immunomedics Inc position peaked at $45.1M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Tudor Investment Corp's 13F filing for Q4 2020, filed 16 Feb 2021.